Syneos Health Close To Being Acquired For 7B - Elliott, Patient Square and Veritas Investment Consortium Lead Deal
SYNHDelisted Stock | USD 42.31 0.07 0.17% |
Under 62% of Syneos Health's investor base is looking to short. The analysis of current outlook of investing in Syneos Health suggests that many traders are alarmed regarding Syneos Health's prospects. Syneos Health's investing sentiment shows overall attitude of investors towards Syneos Health.
Syneos |
A group of investors, including Elliott Investment Management, Patient Square Capital, and Veritas Capital, is close to acquiring Syneos Health Inc for more than 7 billion, including debt.
Read at benzinga.com
Syneos Health Fundamental Analysis
We analyze Syneos Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Syneos Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Syneos Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
Syneos Health is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Syneos Health Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Syneos Health stock to make a market-neutral strategy. Peer analysis of Syneos Health could also be used in its relative valuation, which is a method of valuing Syneos Health by comparing valuation metrics with similar companies.
Peers
Syneos Health Related Equities
RDNT | RadNet | 2.12 | ||||
SHC | Sotera Health | 0.45 | ||||
QGEN | Qiagen NV | 0.20 | ||||
MTD | Mettler Toledo | 0 | ||||
MEDP | Medpace Holdings | 0.13 | ||||
IQV | IQVIA Holdings | 1.05 | ||||
LH | Laboratory | 1.07 | ||||
ICLR | ICON PLC | 1.75 | ||||
CRL | Charles River | 1.78 | ||||
ACRS | Aclaris Therapeutics | 2.20 | ||||
NEOG | Neogen | 3.57 | ||||
MYGN | Myriad Genetics | 5.41 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in Syneos Stock
If you are still planning to invest in Syneos Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Syneos Health's history and understand the potential risks before investing.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Money Managers Screen money managers from public funds and ETFs managed around the world |